TrialInternational journal of radiation oncology, biology, physics2025

Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial.

David J Sher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.